Semaglutide
A synthetic peptide engineered as a selective GLP-1 receptor agonist. Utilized to investigate incretin pathway activation, delayed gastric emptying models, and beta-cell function in preclinical studies.
Semax
A synthetic heptapeptide analogue derived from adrenocorticotropic hormone (ACTH 4-10). Utilized to investigate BDNF/NGF expression, neuroprotection, and cognitive pathway modulation.
SLU-PP-322 (Capsules)
A synthetic small molecule engineered as a highly selective pan-Estrogen Related Receptor (ERR) agonist. Utilized to investigate mitochondrial biogenesis, fatty acid oxidation, and exercise-mimetic signaling pathways.
TB500
A synthetic fraction of the naturally occurring peptide Thymosin Beta-4. Utilized to investigate actin-sequestering properties, cellular motility, and extracellular matrix remodeling.
Tesamorelin
A synthetic, N-terminally modified analogue of growth hormone-releasing hormone (GHRH). Utilized to investigate targeted visceral adipose reduction pathways and basal growth hormone pulsatility.
Tirzepatide
A synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. Utilized to investigate synergistic incretin receptor binding and its effects on intracellular cAMP production.